2016
DOI: 10.1007/s00270-016-1489-9
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis

Abstract: Purpose To evaluate the use of a self-expanding tract sealant device (BioSentry™) on the rates of pneumothorax and chest tube insertion after percutaneous lung biopsy. Material and Methods In this retrospective study, we compared 318 patients who received BioSentry™ during percutaneous lung biopsy (treated group) with 1956 patients who did not (control group). Patient-, lesion-, and procedure-specific variables, and pneumothorax and chest tube insertion rates were recorded. To adjust for potential selection … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
24
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 29 publications
0
24
0
Order By: Relevance
“…However, disadvantages with these materials are local tissue reaction, inflammation and scarring. A recent randomized trial of use of a hydrogel plug has been published . This has been recently approved by US Food and Drug Administration (USFDA) and currently available as BioSentry TM (Surgical Specialties Corporation, Wyomissing, PA, USA).…”
Section: Discussionmentioning
confidence: 99%
“…However, disadvantages with these materials are local tissue reaction, inflammation and scarring. A recent randomized trial of use of a hydrogel plug has been published . This has been recently approved by US Food and Drug Administration (USFDA) and currently available as BioSentry TM (Surgical Specialties Corporation, Wyomissing, PA, USA).…”
Section: Discussionmentioning
confidence: 99%
“…Computed tomography (CT)-guided core needle lung biopsy (CT-CNB) is a reliable and safe diagnostic procedure; the most common complication of CT-CNB is pneumothorax [12]. Some invasive techniques, such as injection of sealant materials (e.g., autologous blood patch, collagen plugs, fibrin glue, normal saline, hydrogel plugs) into the biopsy tract have been studied for their ability to decrease the risk of pneumothorax [345]. The use of an autologous blood patch is perhaps the most widely known technique, but it has shown varying results [6].…”
Section: Introductionmentioning
confidence: 99%
“…In this study, transthoracic needle biopsies were performed using the BioSentry Tract Sealant System because its efficacy in reducing the number of biopsy-related pneumothoraces and chest-tube placements has been validated in other trials. 16 , 19 Although the injected plug is 2.5 cm in length and is deposited peripherally, this study shows that the injection of the hydrogel plug commonly results in a visible and persistent tract within the lung parenchyma that can mimic tumor cell dissemination along the biopsy needle tract.…”
Section: Discussionmentioning
confidence: 80%
“…In this newer transthoracic biopsy technique, a hydrogel plug is injected while withdrawing the needle at the completion of the biopsy procedure to decrease the incidence of pneumothoraces, the most common complication of transthoracic lung biopsy. 16 , 17 , 18 The resulting biopsy tract can be visible within the lung parenchyma on follow-up chest computed tomography (CT) and/or 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) CT imaging and can potentially mimic malignant tract seeding. This could result in a larger gross tumor volume (GTV) and planning target volume (PTV) or larger limited resection in those patients undergoing wedge resection.…”
Section: Introductionmentioning
confidence: 99%